
Neochem Bio Solutions IPO GMP: Day 1 IPO Live Updates
Posted by : sachet | Tue Dec 02 2025

The Neochem Bio Solutions IPO GMP is ₹0 as of 2nd December 2025. It is a bookbuilding IPO of ₹44.97 crores. This is an entirely fresh issue of 46,00,000 shares. The issue will be listed on NSE and SME on its tentative listing date, 9th December 2025. The face value of Neochem Bio Solutions IPO shares is ₹10 per share, and the IPO price band is ₹93 to ₹98 per share. Retail investors can bid for a minimum of 2 lots of 2,000 shares worth ₹2,35,200.
Neochem Bio Solutions IPO GMP Grey Market Premium
As of 2nd December 2025, the Neochem Bio Solutions IPO GMP stands at ₹0 per share. Thus, the estimated listing price would be ₹98. This indicates that the estimated listing gain in this IPO could be 0.00%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for the Neochem Bio Solutions IPO GMP updates.
| GMP Date | IPO Price | GMP | Estimated Listing Price | Estimated Listing Gains |
| 2-12-2025 | ₹98.00 | ₹0.00 | ₹98.00 | 0.00% |
| 1-12-2025 | ₹98.00 | ₹5.00 | ₹98.00 | 0.00% |
| 30-11-2025 | ₹98.00 | ₹9.00 | ₹107.00 | 9.18% |
| 29-11-2025 | ₹98.00 | ₹9.00 | ₹107.00 | 9.18% |
| 28-11-2025 | ₹98.00 | ₹6.00 | ₹104.00 | 6.12% |
| 27-11-2025 | ₹98.00 | ₹6.00 | ₹104.00 | 6.12% |
| 26-11-2025 | ₹98.00 | ₹10.00 | ₹108.00 | 10.20% |
| 25-11-2025 | ₹98.00 | ₹0.00 | ₹98.00 | 0.00% |
| 24-11-2025 | ₹98.00 | ₹0.00 | ₹98.00 | 0.00% |
Neochem Bio Solutions IPO Details
| IPO Allotment Date | 5th December 2025 |
| IPO Open Date | 2nd December 2025 |
| IPO Close Date | 4th December 2025 |
| Refund Initiation | 8th December 2025 |
| Issue Size | 45,88,800 shares(aggregating up to ₹44.97 Cr) |
| Face Value | ₹10 per share |
| Lot Size | 1,200 shares |
| Issue Price | ₹52 to ₹56 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Listing Date | 9th December 2025 |
Explanation
Neochem Bio Solutions IPO: Neochem Bio Solutions IPO Limited has declared an issue price band of ₹93.00 to ₹98.00 per share. With this IPO, the company allows retail investors to bid for at least two lots of 2,400 shares, each worth ₹2,35,000. The face value of Neochem Bio Solutions IPO Limited shares is ₹10 per share. The shares of Neochem Bio Solutions IPO Limited will be listed on NSE and SME on its tentative listing day, 9th December 2025. Scroll down to check GMP updates and Neochem Bio Solutions IPO reviews.
Neochem Bio Solutions IPO Objectives
The primary aim of the Neochem Bio Solutions IPO is to raise ₹44.97 crores. On the other hand, Neochem Bio Solutions has decided to utilise these funds in different ways. Explore some of the secondary objectives for the Neochem Bio Solutions IPO.
- Funding the long-term working capital requirements of the Company
- Repayment/prepayment, in whole or part, of all or certain outstanding borrowings availed by the Company
- General Corporate Purposes
Neochem Bio Solutions IPO Registrar
According to recent updates, MUFG Intime India Limited will be the registrar responsible for managing allotment and refund procedures. For any queries regarding the Neochem Bio Solutions IPO GMP, allotment, or refund, please contact the investor relations team at MUFG Intime India Limited at ipo.helpdesk@linkintime.co.in or +91-22-4918 6270.
Neochem Bio Solutions IPO Review

The Neochem Bio Solutions IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Neochem Bio Solutions Limited’s revenue soared by 39% from ₹62.01 crores in March 2024 to ₹86.15 crores in March 2025. Moreover, the company’s PAT increased by 330% from ₹1.80 crores in March 2024 to ₹7.75 crores in March 2025.
Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we’re waiting for additional ratings to get a clearer picture and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for Neochem Bio Solutions IPO or not.
Neochem Bio Solutions IPO Limited Technicals
| Key Indicators | Value |
| PE Ratio (Price-to-Earnings) | 15.85 |
| EPS (Earnings Per Share) | 6.18 |
| RoNW | 48.82% |
| ROCE | 41.67% |
| ROE | 48.82% |
| EBITDA Margin | 15.58% |
| Price to Book Value | 5.80 |
| Market Capitalisation | ₹167.78 |
The PE ratio of Neochem Bio Solutions Limited shares is 15.85, and its Earnings Per Share (EPS) stands at 6.18. Thus, the Neochem Bio Solutions IPO can potentially deliver gains on its tentative listing date, 9th December 2025.
Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Neochem Bio Solutions Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics.
| Indicators | Pre-IPO | Post-IPO |
| PE Ratio | 15.85 | 15.85 |
| EPS | 6.18 | 6.41 |
FAQs on Neochem Bio Solutions IPO
What is the Neochem Bio Solutions IPO GMP?
Currently, on 2nd December 2025, the Neochem Bio Solutions IPO GMP (Grey Market Premium) stands at ₹0. This indicates that the estimated listing price could be ₹98 per share.
What is the issue price of Neochem Bio Solutions IPO?
The Neochem Bio Solutions IPO issue price band is set at ₹93 to ₹98 per share. Retail investors can apply for a minimum of 2 lots, each consisting of 2,400 shares, worth ₹2,35,200. Moreover, HNIs are required to bid for a minimum of 3 lots (3,600 shares) worth ₹3,52,800.
Who is the registrar of Neochem Bio Solutions IPO?
MUFG Intime India Limited is the registrar for the Neochem Bio Solutions IPO, awaiting to manage the allotment process and initiate refunds. For any queries regarding the Neochem Bio Solutions allotment and refund, you can contact MUFG Intime India Limited at ipo.helpdesk@linkintime.co.in or +91-22-4918 6270.
Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Neochem Bio Solutions IPO, download the Neochem Bio Solutions IPO RHP and Neochem Bio Solutions IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.
Recent Articles
Max Healthcare Q1 Results FY26: Q1 PAT Rises 30.35% to ₹307.97 Crore; Revenue Up 31.41% YoY
Minda Corporation Q1 Results FY26: Q1 PAT Rises 1.73% to ₹65.31 Crore; Revenue Up 16.23% YoY
Bharat Dynamics Q1 Results FY26: Q1 PAT Rises 154.30% to ₹18.35 Crore; Revenue Up 29.69% YoY
Elitecon International Q1 Results FY26: Q1 PAT Rises 349.99% to ₹20.41 Crore; Revenue Up 301.98% YoY
Elgi Equipments Q1 Results FY26: Q1 PAT Rises 17.58% to ₹85.60 Crore; Revenue Up 8.19% YoY
Aavas Financier Q1 Results FY26: Q1 PAT Rises 10.41% to ₹139.23 Crore; Revenue Up 15.70% YoY
Related Posts
Exato Technologies IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Logiciel Solutions IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Purple Wave Infocom IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Western Overseas Study Abroad IPO GMP & Review: Apply or Avoid?
SSMD Agrotech India IPO Listing at 39.67% discount at ₹73 Per Share

